Cyclo (RGDyC)
Cyclo (RGDyC) is a cyclic pentapeptide with anti-angiogenic abilities. Cyclo (RGDyC) can be combined with liposome delivery systems for research on ocular neovascular diseases and cancer[1][2].
Product Specifications
CAS Number
1206475-79-7
UNSPSC
12352209
Target
Biochemical Assay Reagents
Type
Peptides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cyclo-rgdyc.html
Purity
98.29
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C([C@@H](NC(CNC([C@@H](NC([C@@H](NC1=O)CS)=O)CCCNC(N)=N)=O)=O)CC(O)=O)N[C@@H]1CC2=CC=C(C=C2)O
Molecular Formula
C24H34N8O8S
Molecular Weight
594.64
References & Citations
[1]Lu Y, et al. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting. Nanotechnology. 2013 Apr 5;24 (13) :135101.|[2]Tang M, et al. Photostable and Biocompatible Fluorescent Silicon Nanoparticles-Based Theranostic Probes for Simultaneous Imaging and Treatment of Ocular Neovascularization. Anal Chem. 2018 Jul 3;90 (13) :8188-8195.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
